Journal
ESC HEART FAILURE
Volume 8, Issue 5, Pages 3512-3520Publisher
WILEY PERIODICALS, INC
DOI: 10.1002/ehf2.13476
Keywords
Proteomics; Incident heart failure; Sex differences
Categories
Funding
- European Union Commission [305507]
- Netherlands Cardiovascular Research Initiative
- Dutch Heart Foundation
- Contrat de Plan Etat-Lorraine
- FEDER Lorraine
- French National Research Agency (ANR) [ANR-15-RHU-0004]
- French PIA project Lorraine Universite d'Excellence [ANR-15-IDEX-04-LUE]
- Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine
- OMRON Healthcare Co., Ltd., Kyoto, Japan
Ask authors/readers for more resources
This study aimed to test the sex-specificity of 252 protein biomarkers for new-onset heart failure (HF). The majority of biomarkers associated with incident HF did not significantly differ between women and men, despite clear differences in biomarkers at baseline. Four biomarkers showed a trend towards sex-specificity, with E-selectin and interleukin 1 receptor antagonist being more female-specific, and IL17A and CHIT1 tending to be male sex-specific for incident HF.
Aims Heart failure (HF) is common in both men and women, yet disease pathophysiology, presentation, and progression differ between sexes. Studies addressing whether biomarkers predict new onset HF sex-specifically are scarce. This study therefore aims to test the sex-specificity of 252 protein biomarkers for new-onset HF. Methods and results A matched case-control design in patients selected from cohorts within the HOMAGE consortium was used. Cases (new-onset HF, n = 562) and controls (n = 780) were matched for cohort (PREDICTOR, HEALTH-ABC, & PROSPER), follow-up time (defined as time from entry to incident HF), and age. Incident HF was defined as first hospitalization for HF. Targeted plasma proteins (n = 252) were measured using Proximity Extension Assay technology from O-link. To look for sex differences for new onset HF, we adjusted for cohort, age, and baseline clinical parameters. At baseline, women had a biomarker profile reflecting activated metabolism and immune responses. However, none of the biomarkers had a significant interaction with sex in predicting new onset HF, but four biomarkers had a trend towards sex-specificity (P < 0.013). E-selectin and interleukin 1 receptor antagonist were more female-specific, whereas IL17A and CHIT1 tended to be male sex-specific for incident HF. Conclusions The majority of biomarkers associated with incident HF did not significantly differ between women and men, despite clear differences in biomarkers at baseline.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available